Critical illness insurances : challenges and opportunities for insurers
Contenido multimedia no disponible por derechos de autor o por acceso restringido. Contacte con la institución para más información.
Tag | 1 | 2 | Valor |
---|---|---|---|
LDR | 00000cab a2200000 4500 | ||
001 | MAP20150035547 | ||
003 | MAP | ||
005 | 20220911204321.0 | ||
008 | 151030e20151005esp|||p |0|||b|spa d | ||
040 | $aMAP$bspa$dMAP | ||
084 | $a344.1 | ||
100 | 1 | $0MAPA20080644536$aGatzert, Nadine | |
245 | 1 | 0 | $aCritical illness insurances$b: challenges and opportunities for insurers$cNadine Gatzert, Alexander Maegebier |
520 | $aSince the first introduction of critical illness insurance in 1983 in South Africa, the product has successfully spread to some insurance markets, especially in Asian and Anglophone countries, but market penetration remains low in other countries. For this reason and because of the increasing relevance of dread diseases, the aim of this article is to provide a first comprehensive overview of challenges and opportunities associated with critical illness products for insurers. Toward this end,we first present the various product designs, as well as the developments that have taken place within the market before comparing this form of coverage to alternative insurance products in order to better assess the market potential. Based on these assessments, we thoroughly discuss the major challenges and opportunities within the market from the insurer's perspective. | ||
650 | 4 | $0MAPA20080626310$aSeguro de asistencia sanitaria | |
650 | 4 | $0MAPA20080624941$aSeguro de enfermedades graves | |
650 | 4 | $0MAPA20080562236$aEnfermedades | |
650 | 4 | $0MAPA20080598358$aProductos de seguros | |
650 | 4 | $0MAPA20080611880$aPerspectivas del seguro | |
700 | 1 | $0MAPA20140000258$aMaegebier, Alexander | |
773 | 0 | $wMAP20077001748$tRisk management & insurance review$dMalden, MA : The American Risk and Insurance Association by Blackwell Publishing, 1999-$x1098-1616$g05/10/2015 Tomo 18 Número 2 - 2015 , p. 255-272 |